Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7297
    -0.0024 (-0.32%)
     

  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     

  • Bitcoin CAD

    87,897.41
    -3,164.16 (-3.47%)
     

  • CMC Crypto 200

    1,386.71
    -37.39 (-2.63%)
     

  • GOLD FUTURES

    2,329.50
    -8.90 (-0.38%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,483.00
    -181.50 (-1.03%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

Today’s Research Reports on Ceapro, Emerald Health Therapeutics, ESSA Pharma and Sernova

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / April 18, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Ceapro Inc.
https://rdinvesting.com/news/?ticker=CZO.V

Emerald Health Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=EMH.V

ESSA Pharma Inc.
https://rdinvesting.com/news/?ticker=EPI.V

Sernova Corp.
https://rdinvesting.com/news/?ticker=SVA.V

ADVERTISEMENT

Ceapro's stock had no change Tuesday, to close the day at $0.51. The stock recorded a trading volume of 8,350 shares, which was below its three months average volume of 55,879 shares. In the last year, Ceapro's shares have traded in a range of 0.48 - 1.40. The stock is currently trading 63.57% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.53 is below its 200-day moving average of $0.57. Shares of Ceapro are trading at a Price to Earnings ratio of 46.36. Shares of Ceapro have gained approximately 6 percent year-to-date.

Access RDI's Ceapro Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CZO.V

On Tuesday, shares of Emerald Health Therapeutics recorded a trading volume of 1,043,668 shares, which was below the three months average volume of 1,944,273 shares. The stock ended the day 3.73% lower at 4.90. The share price has gained 375.73% from its 52 week low with a 52 week trading range of 1.03 - 25.06. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $6.04 is greater than its 200-day moving average of $3.91. Shares of Emerald Health Therapeutics have fallen approximately 5.95 percent year-to-date.

Access RDI's Emerald Health Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EMH.V

ESSA Pharma's stock moved 4.44% lower Tuesday, to close the day at $0.21. The stock recorded a trading volume of 36,629 shares, which was below its three months average volume of 76,372 shares. In the last year, ESSA Pharma's shares have traded in a range of 0.21 - 3.49. The stock is currently trading 93.84% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.25 is below its 200-day moving average of $0.29. Shares of ESSA Pharma have fallen approximately 20.37 percent year-to-date.

Access RDI's ESSA Pharma Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EPI.V

On Tuesday, shares of Sernova recorded a trading volume of 188,950 shares, which was above the three months average volume of 132,353 shares. The stock ended the day flat at 0.34. The share price has gained 139.29% from its 52 week low with a 52 week trading range of 0.14 - 0.51. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.36 is greater than its 200-day moving average of $0.33. Shares of Sernova have fallen approximately 21.43 percent year-to-date.

Access RDI's Sernova Corp. Research Report at:
hhttps://rdinvesting.com/news/?ticker=SVA.V

Our Actionable Research on Ceapro Inc. (TSXV :CZO.V), Emerald Health Therapeutics, Inc. (TSXV :EMH.V), ESSA Pharma Inc. (TSXV :EPI.V) and Sernova Corp. (TSXV :SVA.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com